- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03367585
Effects of Vitamin D Supplementation in Muscle Strength and Balance Training
April 22, 2020 updated by: University of Sao Paulo General Hospital
Effects of Vitamin D Supplementation in Muscle Strength and Postural Balance Training in Vulnerable Elderly Women
Introduction: In Brazil, a person who is sixty years old or more is considered elderly.
The incidence of osteoporosis and osteopenia has been increasing, as have fractures resulting from falls.
Vitamin D deficiency can cause muscular atrophy in type II fibers (fast contraction and strength), which can increase the risk of falls.
The aging process produces reduction in the ability of postural control system to maintain postural balance, which may increase postural instability and consequently increase the elderly risk to falls.
Objective: To evaluate if vitamin D supplementation associated with regular exercise in vulnerable older women improves muscle strength and postural balance in 12 weeks.
Methods: This will be a randomized prospective clinical trial, double blind, placebo-controlled intervention.
Will be part of the study 40 elderly women vulnerable, who meet the inclusion criteria and that will be coming from the community through calls made by radio and social network.
The volunteer will undergoing to blood test, body composition and bone mineral density, Mini Mental State Examination, Geriatric Depressive Scale, Falls Efficacy Scale, WHOQOL-OLD and WHOQOL-BREF instruments, functional capacity tests (MiniBEST, Time up and Go, Chair Rising Test, Six-minute walk test), muscular strength assessment (isokinetic dynamometry, handgrip and 1RM test) and postural balance (AccSway force platform for static postural balance and NeuroCom's Balance Master for dynamic postural balance) before and after 12 weeks of intervention with vitamin D supplementation and resistance and postural balance exercise.
The intervention that will be perform during the 12 weeks with a progressive resistance training program.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 04503-010
- Julia Maria DÀndrea Greve
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age > 60 years;
- Osteoporosis or osteopenia (bone mineral density lower than -1.5 standard deviations of the T-score);
- Present hypovitaminosis D (<30 nmol / L);
- Do not practice regular resistance exercise;
- Can not have an injury in lower limbs at least on the last three months,;
- Be able to perform independent gait without climbing for at least 100 meters;
- Be independent in your daily life activities;
- Do not present restrictions for the practice of resistance exercises, including having performed a recent exercise test (maximum 6 months);
- Do not use medications such as estrogen's, diuretics, to improve bone mass;
- Do not use dietary supplements with vitamin D;
- Do not present hyperparathyroidism, diabetes, uncontrolled hypertension, hyperprolactinemia, hypercalciuria, renal lithiasis or elevated serum calcium.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
The experimental group, which will supplement vitamin D3 50,000 IU / week, being in two capsules (25,000 IU / week each),
|
Strength exercise + Supplementation of vitamin D3 50,000 IU / week
|
|
Placebo Comparator: Placebo
The placebo group will inject two capsules of equal size, volume and coloration, composed of lactose, without the vitamin D3 supplement.
|
Strength exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postural balance - semi static - change
Time Frame: This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
Evaluation of postural balance - AccSway force platform for semi static postural.
The arithmetic mean of the results was calculated from the three tests conducted under each condition, and was processed using the Balance Clinic software.
The following parameters were used to measure the stability of the participants: medial-lateral and anteroposterior amplitude (cm), the mean velocity calculated from the total displacement of the center of pressure (COP) in all directions (cm/s), and the elliptical area encompassing 95% of the displacement from the COP (cm2).
The following parameters were used to measure the stability of the participants: medial-lateral and anteroposterior amplitude (cm), the mean velocity calculated from the total displacement of the center of pressure (COP) in all directions (cm/s).
|
This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postural balance - dynamic - change
Time Frame: This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
Evaluation of dynamic postural balance - The postural balance assessment (posturography) will be perform on the NeuroCom Balance Master® force platform system (NeuroCom International, Inc., Clackamas, OR, USA).
The variables will be the mean sway speed (cm/s) on a stable surface and an unstable surface; and the mean sway in the anteropoterior direction and mediolateral (cm) direction at the same conditions.
The variables will be the mean weight transfer index (%), mean movement time (s) and mean impact index.
|
This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
|
Muscular strength - Hand Grip - change
Time Frame: This measure will be perform before and after the intervation (12 weeks strenght and potural balance exercise).
|
Evaluation of muscular strength improvement- hand grip strength (HGS).
HGS assessment was performed using a Jamar hand dynamometer, measured in kilograms (kg), which is adopted by the American Society of Hand Therapists (ASHT).
|
This measure will be perform before and after the intervation (12 weeks strenght and potural balance exercise).
|
|
Muscular strength - Isokinetic dynamometry - change
Time Frame: This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
Evaluation of muscular strength improvement - Isokinetic dynamometry will be use to determine knee extension and flexion strength using the Biodex Multi-Joint System 3 (Biodex MedicalTM, Shirley, NY, USA).
The isokinetic variables used were maximum peak torque corrected for body weight (%), and total work (J).
|
This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
|
Muscular strength - 1 maximal repetition (RM)- change
Time Frame: This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
Evaluation of muscular strength improvement - 1RM test.
One-repetition maximum in weight training is the maximum amount of force that can be generated in one maximal contraction (kg).
|
This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
|
Body composition and bone mineral density - change
Time Frame: This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
Evaluation of body composition (area=cm2; BMC=g and BMD=g/cm2) and bone mineral density (BMD=g/cm2; T-score)
|
This measure will be performing before; after the innervation (12 weeks strength and postural balance exercise) and six months after the intervention (six months follow up).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2018
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
April 22, 2020
Study Registration Dates
First Submitted
December 4, 2017
First Submitted That Met QC Criteria
December 7, 2017
First Posted (Actual)
December 8, 2017
Study Record Updates
Last Update Posted (Actual)
April 24, 2020
Last Update Submitted That Met QC Criteria
April 22, 2020
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 306/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis, Postmenopausal
-
National Taiwan University HospitalRecruitingOsteoporosis | Osteoporosis PostmenopausalTaiwan
-
National Taiwan University HospitalNational Taiwan UniversityNot yet recruitingOsteoporosis | Postmenopausal Osteoporosis | Postmenopausal Osteopenia | Primary OsteoporosisTaiwan
-
mAbxience Research S.L.CompletedPostmenopausal Women With OsteoporosisPoland, Serbia, Bulgaria, Georgia, Estonia, Hungary, Latvia, Mexico
-
AmgenCompletedPostmenopausal Osteoporosis (PMO)Japan
-
Deltanoid PharmaceuticalsCompletedPostmenopausal Osteoporosis, Multiple Sites
-
Riphah International UniversityCompletedPostmenopausal Osteoporosis | Postmenopausal OsteopeniaPakistan
-
Riphah International UniversityNot yet recruitingOsteoporosis PostmenopausalPakistan
-
Istanbul Physical Medicine Rehabilitation Training...RecruitingOsteoporosis PostmenopausalTurkey (Türkiye)
-
Bursa City HospitalNot yet recruitingOsteoporosis | Postmenopausal Osteoporosis
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
Clinical Trials on Physical exercise + Vitamin D3
-
Norfolk and Norwich University Hospitals NHS Foundation...Guy's and St Thomas' NHS Foundation Trust; University of East Anglia; Maastricht... and other collaboratorsNot yet recruitingInfant Vitamin K Status | Vitamin K Deficiency Bleeding
-
Aga Khan UniversityCompletedVitamin D DeficiencyPakistan
-
Badr UniversityCompletedVitamin D DeficiencySaudi Arabia
-
Riphah International UniversityRecruitingPlantar Wart | Wart | Common Wart | Warts Hand | Flat Wart | Viral Wart | Common Warts (Verruca Vulgaris) | Warts of FootPakistan
-
Medical University of South CarolinaThrasher Research FundCompletedVitamin D Deficiency | PregnancyUnited States
-
Cairo UniversityNot yet recruitingPlantar Warts Treatment
-
Rutgers UniversityCompleted
-
Aalborg UniversityAalborg University Hospital; CCBR Aalborg A/S, Aalborg, DenmarkCompletedMigraine According to International Headache Society (IHS) Criteria (ICHD-II)Denmark
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaboratorsCompletedHIV InfectionUnited States, Puerto Rico
-
Brigham and Women's HospitalNational Center for Maternal and Child Health Research, Mongolia; Zuun Kharaa...CompletedVitamin D Deficiency | PregnancyMongolia